Kim P Y, Monk B J, Chabra S, Burger R A, Vasilev S A, Manetta A, DiSaia P J, Berman M L
Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange 92668, USA.
Gynecol Oncol. 1998 Jun;69(3):243-7. doi: 10.1006/gyno.1998.5012.
Cervical carcinoma frequently metastasizes to the paraaortic region, necessitating extended field radiotherapy to effect a cure. As imaging modalities are unreliable in identifying all cases of paraaortic nodal metastases (PAN), surgical staging is often utilized prior to radiotherapy. This study was aimed at identifying factors predictive of survival in women with cervical carcinoma and paraaortic metastases. In particular, survival based on extent of paraaortic disease was examined. The study group consisted of 43 women (stages IB-IVB) identified between 1982 and 1993 who were treated with extended field radiation for cervical carcinoma with histologically confirmed paraaortic metastases. The estimated 5-year survival for the study population was 24% with a median survival of 18 months. Pelvic tumor size had a significant impact on survival with the median survival being 34 months if the primary lesion was < 6 cm compared to 14 months if > or = 6 cm (P = 0.01). Eight of the 26 (31%) women without residual PAN disease after surgical staging remain alive and disease free (mean follow-up, 74 months). In contrast, only 1 of the 17 (6%) women with gross residual PAN is alive 71 months after treatment (P = 0.05). However, a comparison of Kaplan-Meier survival curves did not show a statistically significant advantage to the surgical excision of grossly involved PAN (P = 0.98). Although long-term survival among women with grossly involved, unresected paraaortic metastases is uncommon, further study is necessary to elucidate the role of surgical excision of bulky aortic disease in women with cervical cancer.
宫颈癌常转移至腹主动脉旁区域,因此需要扩大野放疗以实现治愈。由于影像学检查手段在识别所有腹主动脉旁淋巴结转移(PAN)病例方面并不可靠,所以在放疗前常采用手术分期。本研究旨在确定宫颈癌伴腹主动脉旁转移患者的生存预测因素。特别对基于腹主动脉旁疾病范围的生存情况进行了研究。研究组由1982年至1993年间确诊的43例(IB - IVB期)宫颈癌伴组织学证实的腹主动脉旁转移患者组成,这些患者均接受了扩大野放疗。研究人群的估计5年生存率为24%,中位生存期为18个月。盆腔肿瘤大小对生存有显著影响,若原发灶<6 cm,中位生存期为34个月;若≥6 cm,则为14个月(P = 0.01)。手术分期后无残留PAN疾病的26例女性中有8例(31%)仍存活且无疾病(平均随访74个月)。相比之下,17例有明显残留PAN的女性中只有1例在治疗后71个月仍存活(P = 0.05)。然而,比较Kaplan - Meier生存曲线发现,手术切除明显受累的PAN并无统计学上的显著优势(P = 0.98)。尽管有明显受累、未切除的腹主动脉旁转移的女性长期生存并不常见,但仍需进一步研究以阐明切除肿大的主动脉旁疾病在宫颈癌女性中的作用。